Conference Presentation, Panel
Leading the Charge: CEOs Navigating Business Transformation | Global Conference 2025
Milken InstituteSara Eisen, Joaquin Duato, Robbert Rietbroek, Janet Truncale, Igor Tulchinsky, Robin Vince
- US administration policy shifts and geopolitical friction are creating a complex environment where clients require clarity on strategic objectives beyond tactical noise, with tariffs viewed as potential supply chain disruptions in pharmaceuticals but manageable "blips" for the beverage sector which remains 99% domestically sourced.
- Artificial Intelligence is predicted to fundamentally transform every industry over the next 5, 10, or 15 years, with efficiency gains ranging from 20 to 40 percent for established firms and tens of times greater efficiency for new AI-native entities, while capacity improvements in specific areas may reach 60 to 70 percent.
- The healthcare sector aims to elevate innovation to cure diseases, projecting a transition of cancers like multiple myeloma from fatal conditions with 2-3 year survival rates to chronic conditions with over 10 years of survival, alongside a strategic focus on neurodegenerative diseases expected to rise as populations age past 85.
- A $55 billion investment over the next four years is planned to expand US manufacturing capacity for medical technologies and pharmaceuticals, representing a 25% increase, with the specific goal of sourcing and selling all demand domestically and utilizing tax reform like the TCJA to support this rather than relying solely on tariffs.
- The professional services firm intends to support client decision-making during economic uncertainty, noting that over half of CEOs are planning M&A to accelerate transformation, while the firm itself plans to double its workforce size and invest in learning to engage a Gen Z demographic expected to comprise 70% of the workforce within nine years.
- The beverage sector anticipates continued demand and expansion even during recessionary periods, driven by premium brand growth among consumers seeking healthy hydration as alcohol consumption declines, with Nielsen and Circana scans confirming first-quarter strength.
- Capital allocation strategies across sectors prioritize organic growth combined with M&A, with specific guardrails such as the beverage company acquiring only natural product brands for the next few years, while the professional services firm seeks to pivot toward an ecosystem of partners to handle businesses that make up more than half of its volume.
- ESG and sustainability remain core priorities with emission and waste goals staying consistent, evolving into a billion-dollar service opportunity where sustainability is embedded into broader transformation agendas.
- Regulatory and strategic risks include potential national security implications for critical medicines requiring 232 investigations for strategic autonomy, concerns about the speed of AI adaptation for large populations, and the competitive necessity for companies to implement AI within the next two to five years or risk failure.
- Future workforce and operational models involve integrating AI into drug discovery, 3D heart mapping, financial reporting, advertising, and logistics, while WorldQuant plans to launch a graduate-level AI education program to teach rapidly changing subjects.